(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

Q

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

Q

ST13

US500000076279452

Class

5, 16, 35, 38, 39, 42

Filing

76279452

Registration

2813534

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

01/11/2026

Trademark type

Combined

Nice classes

5, 16, 35, 38, 39, 42

Filing date

07/02/2001

Registration date

02/10/2004

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/22/2024

Last transaction

01/11/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/12/1996

First use in commerce

11/12/1996

Drawing code

3

Owner type

16

Owner location

Wilmington, DE

Examiner

COGGINS,ROBERT H

Law office

M60

Holders and representatives

Holders

QUEST DIAGNOSTICS INVESTMENTS LLC
Q. I. (pessoa física)

Representatives

Karen C. Kline DUANE MORRIS LLP

Technical classification

Nice Classes

Class 5Class 16Class 35Class 38Class 39Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

diagnostic reagents and assays for the treatmentmonitoringdiagnosis of diseaseinfectious diseaseallergiesmicrobial diseasepregnancy-related diseasebacterial diseaseheart diseaseviral diseasehistological diseasegenetic diseaseblood-related diseasefungal diseaseadrenal diseasecancerliver diseaseautomimmune diseasegrowth disorderdiabetes; diagnostic reagents and assays for the treatmentmonitoringdiagnosing of disease; diagnostic reagents for clinical and medical laboratory use; diagnostic kits consisting primarily of diagnostic assaysspecimen holdersdiagnostic preparation agentsspecimen preparation agent for the treatmentmonitoringdiagnosis of disease; diagnostic kits consisting primarily of diagnostic assaysspecimen holdersdiagnostic preparation agentsspecimen preparation agents for clinical and medical use

Class 16

printed reports featuring laboratoryclinical or diagnostic testing and results; printed informationreportspamphletsbrochures and leaflets featuring diagnostic testing or health information; printed informationreportspamphletsbrochures and leaflets providing information on medicalhospitalinsurancebilling records; and instruction sheets regarding medical testing procedures and medical testing results

Class 35

Computerized database management for tracking patient information for diagnostic testing; referral services in the fields of medicalhealth and clinical care; product demonstration services in the field of medical diagnostic testing; computerized database management of diagnostic testing and results; computerized database management of medicalhospitalinsurance and billing records; and providing information regarding hospital billing records

Class 38

Electronic transmission of diagnostic data and medical information via a global computer network in the fields of medicalclinical and health care; electronic transmission of medicalhospitalinsurance and billing records; and electronic transmission of information describing diagnostic testing and health information; and remote data access services to be used in the treatmentmonitoringdiagnosis of disease of biological samples for medical use

Class 39

computer serviceselectronic storage and retrieval of messages and data in the fields of diagnostic testing and preparations for the treatmentmonitoring and diagnosing of disease; computer serviceselectronic storage and retrieval of biological specimens and diagnostic assays

Class 42

medical and testing information servicesproviding information regarding diagnostic testing resultstesting proceduresdisease conditions and disease prevention; and providing information regarding medical and hospital records; and medical and scientific consultation services

Publications

History of USPTO decisions and trademark events.

49 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/09/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/09/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/09/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/09/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/09/2026

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

05/22/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/22/2024

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

05/22/2024

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

05/22/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/20/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

02/06/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/23/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED

01/27/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/27/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/27/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/27/2014

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

01/10/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/10/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

01/10/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/15/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/15/2010

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/12/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/12/2010

E815

TEAS SECTION 8 & 15 RECEIVED

02/08/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

02/10/2004

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/12/2003

DOCK

ASSIGNED TO EXAMINER

12/11/2003

CFIT

CASE FILE IN TICRS

12/09/2003

MAIL

PAPER RECEIVED

10/22/2003

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/21/2003

IUAF

USE AMENDMENT FILED

10/21/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

04/22/2003

PUBO

PUBLISHED FOR OPPOSITION

01/28/2003

NPUB

NOTICE OF PUBLICATION

01/08/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2002

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

11/13/2002

EXPI

EX PARTE APPEAL-INSTITUTED

11/13/2002

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

10/24/2002

DOCK

ASSIGNED TO EXAMINER

10/15/2002

DOCK

ASSIGNED TO EXAMINER

10/08/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/13/2002

MAIL

PAPER RECEIVED

09/13/2002

CNFR

FINAL REFUSAL MAILED

04/09/2002

DOCK

ASSIGNED TO EXAMINER

04/05/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/13/2002

MAIL

PAPER RECEIVED

03/13/2002

CNRT

NON-FINAL ACTION MAILED

09/13/2001

DOCK

ASSIGNED TO EXAMINER

08/28/2001

DOCK

ASSIGNED TO EXAMINER

08/24/2001

Continuous trademark protection

Get notified about every new filing that threatens Q or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.